Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kania Edwin M Jr
Relationship:   10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   19    
Direct Shares   11,445,835    

Indirect Shares

   62,961,806      
Direct Value   $120,000,087    

Indirect Value

   $172,041,820      
Total Shares   74,407,641      
Total Value   $292,041,907      


Exact Sciences Corp $9,315,162 Tetraphase Pharmaceuticals Inc $275,125 Acceleron Pharma Inc $5,136,203 Carisma Therapeutics Inc $2,833,260 Concert Pharmaceuticals, Inc. $5,494,821 Selecta Biosciences Inc $13,373 Syros Pharmaceuticals, Inc. $12,916,140 Editas Medicine, Inc. $15,700,974 Quanterix Corp $34,152,926 Moderna, Inc. $0 Transmedics Group, Inc. $34,162,103 Exact Sciences Corp $9,315,162 Tetraphase Pharmaceuticals Inc $275,125 Acceleron Pharma Inc $5,136,203 Carisma Therapeutics Inc $2,833,260 Concert Pharmaceuticals, Inc. $5,494,821 Selecta Biosciences Inc $13,373 Syros Pharmaceuticals, Inc. $12,916,140 Editas Medicine, Inc. $15,700,974 Quanterix Corp $34,152,926 Moderna, Inc. $0 Transmedics Group, Inc. $34,162,103
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   115.9%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Exact Sciences Corp EXAS Director 2009-07-20 172,503 2009-07-20 1,202,787    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH 10% Owner 2013-03-25 1,165,786 2013-03-25 0    Premium*  
            Acceleron Pharma Inc XLRN Director 2014-12-23 28,734 2014-12-23 544,055    Premium*  
            DNIB Upwind Inc BIND 10% Owner 2013-09-25 0 2013-09-25 1,562,616    Premium*  
            Carisma Therapeutics Inc CARM 10% Owner 2016-09-23 1,940,589 0    Premium*  
            Concert Pharmaceuticals, Inc. CNCE 10% Owner 2014-02-19 656,490 0    Premium*  
            T2 Biosystems, Inc. TTOO 10% Owner 2014-08-12 0 2014-08-12 2,374,571    Premium*  
            Bg Medicine, Inc. BGMD 10% Owner 2014-12-04 0 2014-12-11 4,915,402    Premium*  
            Seres Therapeutics, Inc. MCRB 10% Owner 0 2016-05-25 0    Premium*  
            Selecta Biosciences Inc SELB Director 2017-05-16 26,528 2017-05-16 560,067    Premium*  
            Syros Pharmaceuticals, Inc. SYRS 10% Owner 2017-08-17 2,378,663 2017-08-17 262,386    Premium*  
            Editas Medicine, Inc. EDIT 10% Owner 2016-08-11 2,764,256 2016-08-11 45,422    Premium*  
            Quanterix Corp QTRX 10% Owner 2017-12-11 2,030,495 2017-12-11 0    Premium*  
            Evelo Biosciences Inc EVLO 10% Owner 2018-05-11 0 2018-05-11 18,233,403    Premium*  
            Rubius Therapeutics, Inc. RUBY 10% Owner 2018-07-20 0 2018-07-20 7,563,703    Premium*  
            Moderna, Inc. MRNA 10% Owner 2020-01-14 23,847 2019-12-11 20,253,972    Premium*  
            Kaleido Biosciences, Inc. KLDO 10% Owner 0 2019-03-04 2,682,840    Premium*  
            Transmedics Group, Inc. TMDX 2023-05-25 257,944 2023-05-25 46,142    Premium*  
            Axcella Health Inc. AXLA 10% Owner 0 2019-05-08 2,714,440    Premium*  
* Premium Members only  

Records found :    78         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AXLA Axcella Health Inc. 10% Owner   –       –       •   2019-05-08 3 IO $0.00 $0 I/I 0 2,714,440 -
BGMD Bg Medicine, Inc. 10% Owner   –       –       •   2014-12-04 4 A $0.00 $0 I/I 634,390 604,149 0 -
BGMD Bg Medicine, Inc. 10% Owner   –       –       •   2014-12-09 4 S $0.36 $47,552 I/I (132,090) 478,360 0 -
BGMD Bg Medicine, Inc. 10% Owner   –       –       •   2014-12-10 4 S $0.32 $36,710 I/I (114,720) 369,112 0 -
BGMD Bg Medicine, Inc. 10% Owner   –       –       •   2014-12-11 4 S $0.30 $116,274 I/I (387,580) 0 0 -
BIND DNIB Upwind Inc 10% Owner   –       –       •   2013-09-25 4 A $0.00 $0 I/I 1,542,616 1,542,616 0 -
BIND DNIB Upwind Inc 10% Owner   –       –       •   2013-09-25 4 B $15.00 $300,000 I/I 20,000 1,562,616 1.5 -
CARM Carisma Therapeutics Inc 10% Owner   –       –       •   2014-02-05 3 IO $0.00 $0 D/D 0 419,852 -
CARM Carisma Therapeutics Inc 10% Owner   –       –       •   2014-02-11 4 B $10.00 $3,787,290 D/D 378,729 293,268 2.45 -
CARM Carisma Therapeutics Inc 10% Owner   –       –       •   2014-02-11 4 A $0.00 $0 D/D 2,574,844 260,356 0 -
CARM Carisma Therapeutics Inc 10% Owner   –       –       •   2016-09-06 4 S $4.63 $165,615 D/D (35,770) 290,160 0 -
CARM Carisma Therapeutics Inc 10% Owner   –       –       •   2016-09-07 4 S $4.51 $422,709 D/D (93,727) 282,015 0 -
CARM Carisma Therapeutics Inc 10% Owner   –       –       •   2016-09-19 4 S $3.31 $32,107 D/D (9,700) 270,738 0 -
CARM Carisma Therapeutics Inc 10% Owner   –       –       •   2016-09-20 4 S $3.39 $182,779 D/D (53,917) 259,960 0 -
CARM Carisma Therapeutics Inc 10% Owner   –       –       •   2016-09-21 4 S $3.75 $1,210,211 D/D (322,723) 195,451 0 -
CARM Carisma Therapeutics Inc 10% Owner   –       –       •   2016-09-22 4 S $3.17 $1,194,442 D/D (376,351) 120,198 0 -
CARM Carisma Therapeutics Inc 10% Owner   –       –       •   2016-09-23 4 S $3.10 $208,856 D/D (67,071) 106,787 0 -
CNCE Concert Pharmaceuticals, ... 10% Owner   –       –       •   2014-02-12 3 IO $0.00 $0 D/D 0 32,508 -
CNCE Concert Pharmaceuticals, ... 10% Owner   –       –       •   2014-02-19 4 A $0.00 $0 D/D 623,982 656,490 0 -
EDIT Editas Medicine, Inc. 10% Owner   –       –       •   2016-08-11 4 D $0.00 $0 I/I (350,271) 0 0 -
EDIT Editas Medicine, Inc. 10% Owner   –       –       •   2016-08-11 4 D $0.00 $0 D/D (1,200,000) 2,764,256 0 -
EVLO Evelo Biosciences Inc 10% Owner   –       –       •   2018-05-11 4 A $0.00 $0 I/I 14,622,143 17,952,153 0 -
EVLO Evelo Biosciences Inc 10% Owner   –       –       •   2018-05-11 4 B $16.00 $4,500,000 I/I 281,250 18,233,403 1.5 -
EXAS Exact Sciences Corp Director   –       •      –    2005-10-26 4 A $2.08 $9,999 D/D 4,807 82,036 -
EXAS Exact Sciences Corp Director   –       •      –    2006-07-21 4 A $2.09 $9,999 D/D 4,784 86,820 -
  78  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us